Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder - No Study Results Posted

Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder (SCORPIO)

This study has been completed.

Study NCT00689104 Information provided by Astellas Pharma Inc

First Received: May 29, 2008 Last Updated: March 23, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2009
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: March 23, 2010